EFFICACY OF CV 205-502 IN PATIENTS WITH HYPERPROLACTINEMIA
EFFICACY OF CV 205-502 IN PATIENTS WITH HYPERPROLACTINEMIA
批准号:
3887108
负责人:
MARY LEE VANCE
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CV 205-502, a non-ergot dopamine agonist, will be used to treat
hyperprolactinemic patients for at least 6 months to determine its
efficacy in reducing prolactin secretion and in reducing tumor size in
patients who have demonstratable tumors. The dose of CV 205-502 will be
increased as needed to effect greater reduction in prolactin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DETERMINATION OF THE SERUM HALF LIFE OF ENDOGENOUS GH IN NORMAL MEN
-
批准号:3949974
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
EFFICACY OF TESTOSTERONE THERAPY IN HYPOGONADISM
-
批准号:3976328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
EFFICACY, SYSTEMIC TOLERANCE AND TOPICAL SAFETY OF TRANSDERMAL TESTOSTERONE
-
批准号:3906639
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
HUMATROPE EFFECTS ON GROWTH HORMONE BINDING PROTEIN
-
批准号:3887166
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
SANDOSTATIN IN THE TREATMENT OF ACROMEGALY
-
批准号:3887167
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
DETERMINATION OF THE SERUM HALF LIFE OF ENDOGENOUS GH IN NORMAL MEN
-
批准号:3927453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
SANDOSTATIN ON GH SECRETION AND CARBOHYDRATE LIPID AND PROTEIN METABOLISM
-
批准号:3851432
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
DOSE RANGING STUDY OF CGS-15873A IN HYPEPROLACTINEMIC PATIENTS
-
批准号:3851434
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
SUBCUTANEOUS SYNTHETIC GH DOSE RESPONSE STUDY IN NORMAL MAN
-
批准号:3851400
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
CABERGOLINE IN THE TREATMENT OF PROLACTIN SECRETING PITUITARY MACROADENOMA
-
批准号:3851433
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
CABERGOLINE IN THE TREATMENT OF PROLACTIN SECRETING PITUITARY MACROADENOMA
-
批准号:3787734
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
SUBCUTANEOUS SYNTHETIC GROWTH HORMONE RESPONSE STUDY IN NORMAL MAN
-
批准号:3765708
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
PROGESTERONE THERAPY ON GONADOTROPIN SECRETING PSYCHOLOGICAL SYMPTOMS IN PMS
-
批准号:3887180
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
SAFETY AND EFFICACY OF CHRONIC SANDOSTATIN TREATMENT IN ACROMEGALIC PATIENTS
-
批准号:3851376
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
PHYSIOLOGIC GH REPLACEMENT--PROTEIN, LIPID AND CARBOHYDRATE METABOLISM
-
批准号:3851375
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
INVESTIGATION OF CV 201-502 IN THE TREATMENT OF HYPERPROLACTINEMIC WOMEN
-
批准号:3927452
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
EFFICACY, SYSTEMIC TOLERANCE, TOPICAL SAFETY OF TRANSDERMAL TESTOSTERONE
-
批准号:3949971
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
DETERMINATION OF CLINICAL EFFECTS AND DOSE RESPONSE RELATIONSHIPS OF GH
-
批准号:3949975
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
SUBCUTANEOUS SYNTHETIC GH DOSE RESPONSE STUDY IN NORMAL MAN
-
批准号:3866077
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
STUDY OF NUTROPIN IN TREATMENT OF GROWTH HORMONE DEFICIENT ADULTS
-
批准号:3743523
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARY LEE VANCE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:周秀萍
-
依托单位:
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
-
批准号:82171969
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2021
-
负责人:王雪梅
-
依托单位:
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
-
批准号:82060323
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:何玉林
-
依托单位:
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
-
批准号:81460271
-
项目类别:地区科学基金项目
-
资助金额:46.0万元
-
批准年份:2014
-
负责人:王雪梅
-
依托单位:
11C-dopamine PET/CT显像对急性心肌缺血状况下交感神经功能变化的实验研究
-
批准号:81060019
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:王雪梅
-
依托单位: